Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"excerpt":{"rendered":"
Source-based drug interaction information. Detailed information is available with page access.<\/p>","protected":true},"ism_preview":{"drugs":[{"title":"Buprenorphine","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=buprenorphine","facts":[{"label":"Active ingredient \/ generic name","value":"buprenorphine"}]},{"title":"Efavirenz","url":"https:\/\/www.ortaakarsu.net\/?ism_drug=efavirenz","facts":[{"label":"Active ingredient \/ generic name","value":"efavirenz"},{"label":"Administration route","value":"Oral"}]}],"record":[{"label":"Record type","value":"Published interaction record"},{"label":"Source record version","value":"SPL version 7; effective 2025-03-28; retrieved 2026-11-04; section 7"}],"sources":[{"label":"DailyMed: buprenorphine prescribing information","url":"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=d5a8c41e-413e-4d48-9739-d158e5681dd0"},{"label":"FDA clinical CYP interaction examples","url":"https:\/\/www.fda.gov\/drugs\/drug-interactions-labeling\/healthcare-professionals-fdas-examples-drugs-interact-cyp-enzymes-and-transporter-systems"}],"reviewed_at":"2026-11-04"},"ism_access":{"required":true,"resource_key":"pair:34787","available":true}}